What is the pediatric dose of lactulose for constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pediatric Lactulose Dosing for Constipation

For infants, start with 2.5-10 mL daily in divided doses; for older children and adolescents, use 40-90 mL daily, with the goal of producing 2-3 soft stools per day. 1

Age-Specific Dosing Guidelines

Infants (Under 6 Months)

  • Initial dose: 2.5-10 mL daily in divided doses 1
  • Lactulose/lactitol-based medications are authorized and effective before 6 months of age 2
  • If diarrhea develops, reduce the dose immediately; if diarrhea persists, discontinue lactulose 1

Infants and Young Children (6 Months to 6 Years)

  • Start with 1 sachet/day (approximately 6 g lactulose per sachet) 3
  • Polyethylene glycol becomes an option after 6 months and may be superior to lactulose 2
  • Adjust dose based on response to achieve 2-3 soft stools daily 1

Older Children and Adolescents (6-15 Years)

  • Initial dose: 40-90 mL daily (total daily dose) 1
  • Can start with 2 sachets/day and titrate as needed 3
  • The subjective goal remains producing 2-3 soft stools daily 1

Dose Titration Strategy

Adjust the dose every 1-2 days based on stool frequency and consistency 1:

  • If inadequate response after initial dosing, increase gradually
  • If diarrhea occurs, reduce dose immediately 1
  • Target: 2-3 soft (not watery) bowel movements per day 1

Important Clinical Considerations

Comparative Efficacy

  • PEG 3350 demonstrates superior efficacy compared to lactulose in pediatric constipation 3
  • In a randomized controlled trial, PEG 3350 achieved 56% success rate versus 29% with lactulose 3
  • PEG 3350 causes less abdominal pain, straining, and pain at defecation than lactulose 3
  • Consider PEG 3350 as first-line therapy when available, particularly for children over 6 months 3, 2

Common Pitfalls to Avoid

  • Bloating and flatulence are dose-dependent side effects that occur in approximately 20% of patients 4, 5
  • Primary care physicians tend to undertreat childhood constipation—nearly 40% of children remain symptomatic after 2 months when treated inadequately 6
  • Fixed dosing without clear instructions to adjust is a major treatment failure point—only 5% of physicians in one study instructed parents to titrate doses 6

Disimpaction Protocol

  • For fecal impaction, use higher initial doses or consider rectal disimpaction first 6, 2
  • Children who underwent colonic evacuation followed by daily laxative therapy had significantly better outcomes than those treated less aggressively 6
  • After disimpaction, transition to maintenance dosing as outlined above 1

Monitoring and Side Effects

  • Watch for excessive diarrhea, which can lead to hypokalemia and hypernatremia 4
  • Monitor for abdominal pain and bloating, which may require dose reduction 4
  • Treatment duration should be sufficient—typically months, not weeks—to prevent relapse 1, 2

When Lactulose May Not Be Optimal

  • Lactulose has very low certainty of evidence even in adults 7
  • In pediatric populations, PEG 3350 at 0.26 g/kg provided better success with fewer side effects compared to lactulose at 0.66 g/kg 3
  • For infants under 18 months, PEG 3350 at 0.78 g/kg/day is safe and effective with 97.6% response rate 8

References

Research

[Constipation in infants and children: How should it be treated?].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2016

Guideline

Lactulosa-Associated Adverse Effects

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diabetic Constipation Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Polyethylene glycol for constipation in children younger than eighteen months old.

Journal of pediatric gastroenterology and nutrition, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.